Finance

Lists
Why is RADLY down 8,69%?
Dive Deeper
RADLY:OTCMKTS
RAIA DRAGOSIL ADR
3,80 USD
-8,69%
(-0,36) 1D
16-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RADLY...
Open
3,81 USD
High
3,81 USD
Low
3,80 USD
Mkt. cap
36,03 млд
Avg. vol.
212,68 миң
Volume
791,00
52-wk high
5,34 USD
52-wk low
3,10 USD
Beta
0,18
Shares outstanding
1,75 млд
No. of employees
76 миң
Open
3,81 USD
High
3,81 USD
Low
3,80 USD
Mkt. cap
36,03 млд
Avg. vol.
212,68 миң
Volume
791,00
52-wk high
5,34 USD
52-wk low
3,10 USD
Beta
0,18
Shares outstanding
1,75 млд
No. of employees
76 миң
News stories
From web sources and news partners
Profile
RD Saúde is the largest drugstore company in Latin America by revenue and market capitalization. With its headquarters in São Paulo, it has more than 3,000 pharmacies in Brazil with a national presence in all 27 states. The company's pharmacies are branded as Raia and Drogasil and are supplied by 14 distribution centers. The company also leads in online audience through its proprietary Raia and Drogasil mobile apps and websites, which accounted for 15.2% of 2023 retail gross revenues according to publicly filed financial statements. The company has 3.614 stores around Brazil. RD Saúde's top 3 competitors include Grupo DPSP, Pague Menos and Farmácias São João. Wikipedia
About RAIA DRAGOSIL ADR
CEORenato Cepollina Raduan
Employees75,6 миң
Founded2011-ж., 10-ноя.
Headquarters-
SectorDrug
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
11,26 млд
12,10 млд
10,57 млд
11,06 млд
Cost of goods sold
7,95 млд
8,54 млд
7,17 млд
7,36 млд
Cost of revenue
7,95 млд
8,54 млд
7,17 млд
7,36 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,58 млд
2,82 млд
2,75 млд
2,85 млд
Operating expense
2,58 млд
2,82 млд
2,94 млд
2,86 млд
Total operating expenses
10,53 млд
11,36 млд
10,11 млд
10,22 млд
Operating income
733,50 млн
747,67 млн
456,29 млн
838,88 млн
Other non operating income
-46,23 млн
-62,76 млн
-28,28 млн
-48,97 млн
EBT including unusual items
544,56 млн
303,18 млн
126,80 млн
530,34 млн
EBT excluding unusual items
427,87 млн
358,24 млн
129,38 млн
512,80 млн
Income tax expense
82,88 млн
12,64 млн
-20,47 млн
114,08 млн
Effective tax rate
15,22%
4,17%
-16,14%
21,51%
Other operating expenses
-
-
192,84 млн
5,72 млн
Net income
453,97 млн
304,92 млн
158,96 млн
424,54 млн
Net profit margin
4,03%
2,52%
1,50%
3,84%
Earnings per share
0,24
0,18
0,18
0,21
Interest and investment income
12,87 млн
-
2,75 млн
3,44 млн
Interest expense
-273,30 млн
-329,34 млн
-301,14 млн
-280,37 млн
Net interest expenses
-260,44 млн
-329,34 млн
-298,39 млн
-276,94 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
920,95 млн
1,02 млд
662,92 млн
1,05 млд
Gain or loss from assets sale
8,28 млн
55,46 млн
639,00 миң
48,48 млн
AI content may include mistakes. Learn more
Google колдонмолору